IsoPlexis announced the appointment of Richard Rew as Senior VP, General Counsel and Secretary; Raj Khakhar as VP of Finance; and Manny Resendes as Global Controller. These three new appointments further strengthen the company?s financial and legal teams. Mr. Rew comes to the company with nearly 15 years of experience in the biotechnology industry. He previously served as chief compliance officer and Senior VP, General Counsel and Secretary at Luminex Corporation, where he oversaw legal, compliance and corporate development matters. Before joining the company, Mr. Khakhar served as Director of Finance for the Corporate FP&A Team at Thermo Fisher Scientific. Prior to that he was Senior Director of Finance at the Lojack Corporation. With more than 20 years working in corporate finance, Mr. Khakhar has helped companies grow, restructure, and navigate mergers and acquisitions. Mr. Resendes also comes to the company with over 20 years of accounting and finance experience. As Finance Director, Global Instrument Operations at PerkinElmer Inc., Mr. Resendes led a finance and accounting team supporting seven manufacturing facilities in Canada, China, Italy, Singapore, the U.K. and the U.S. His areas of expertise include cost accounting, budgeting, financial reporting and development of internal management reports.